Kenneth C. Frazier

2016

In 2016, Kenneth C. Frazier earned a total compensation of $21.8M as Chairman, President and Chief Executive Officer at Merck & Co., a 10% decrease compared to previous year.

Compensation breakdown

Change in Pension Value and Nonqualified Deferred Compensation Earnings$4,757,350
Non-Equity Incentive Plan$2,518,425
Option Awards$4,800,002
Salary$1,527,404
Stock Awards$7,875,521
Other$302,468
Total$21,781,170

Frazier received $7.9M in stock awards, accounting for 36% of the total pay in 2016.

Frazier also received $4.8M of change in pension value and nonqualified deferred compensation earnings, $2.5M in non-equity incentive plan, $4.8M in option awards, $1.5M in salary and $302.5K in other compensation.

Rankings

In 2016, Kenneth C. Frazier's compensation ranked 95th out of 14,075 executives tracked by ExecPay. In other words, Frazier earned more than 99.3% of executives.

ClassificationRankingPercentile
All
95
out of 14,075
99th
Division
Manufacturing
28
out of 5,486
100th
Major group
Chemicals And Allied Products
8
out of 1,900
100th
Industry group
Drugs
7
out of 1,543
100th
Industry
Pharmaceutical Preparations
7
out of 1,173
99th
Source: SEC filing on April 10, 2017.

Frazier's colleagues

We found four more compensation records of executives who worked with Kenneth C. Frazier at Merck & Co. in 2016.

2016

Adam Schechter

Merck & Co.

Executive Vice President and President, Global Human Health

2016

Robert Davis

Merck & Co.

Chief Financial Officer

2016

Roger Perlmutter

Merck & Co.

Executive Vice President and President, Merck Research Laboratories

2016

Michael Holston

Merck & Co.

General Counsel

News

You may also like